Back
Vericel 10K Form
Sell
43
VCEL
Vericel
Last Price:
$41.29
Seasonality Move:
-6.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-08 | 10Q | VCEL/Vericel Quarterly |
| 2023-08-02 | 10Q | VCEL/Vericel Quarterly |
| 2023-05-10 | 10Q | VCEL/Vericel Quarterly |
| 2022-11-09 | 10Q | VCEL/Vericel Quarterly |
| 2022-08-03 | 10Q | VCEL/Vericel Quarterly |
| 2022-05-04 | 10Q | VCEL/Vericel Quarterly |
Receive VCEL News And Ratings
See the #1 stock for the next 7 days that we like better than VCEL
VCEL Financial Statistics
Sales & Book Value
| Annual Sales: | $237.2M |
|---|---|
| Cash Flow: | $-7.6M |
| Price / Cash Flow: | 1104.8 |
| Annual Sales: | $5.88 |
| Price / Book: | 7.04 |
Profitability
| EPS (TTM): | 0.03000 |
|---|---|
| Net Income (TTM): | $3M |
| Gross Margin: | $172.1M |
| Return on Equity: | 1.13% |
| Return on Assets: | 0.75% |
Vericel Earnings Forecast
Key Vericel Financial Ratios
-
The Gross Profit Margin over the past 29 years for VCEL is 72.55%.
-
The Selling, General & Administrative Expenses for VCEL have been equal to 60.19% of Gross Profit Margin.
-
The Research & Development expenses have been 10.45% of Revenue.
-
The Interest Expense is 5.93% of Operating Income.
-
The Net Earning history of VCEL is 4.37% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Vericel Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCEL |
| CUSIP: | 92346J |
| Website: | vcel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.01 |
| Quick Ratio: | 4.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 206.75 |
|---|---|
| Forward P/E Ratio: | 52.12 |